LRRK2 and Parkinson disease: When compared with the unidentified group, patients with PD carrying LRRK2 c.4883G>C (p.Arg1628Pro) had a younger age of onset and significantly lower MDS‐UPDRS scores in all four parts recorded (Table 3).